The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases
ConclusionsCurrent evidence does not support the use of second look surgery with oxaliplatin HIPEC or prophylactic oxaliplatin HIPEC in patients with
high risk colon cancer nor the use of oxaliplatin HIPEC with CRS of colorectal PM.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Eloxatin | Peritoneal Cancer | Study